Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.3K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Uniform zinc oxide nanowire arrays grown on nonepitaxial surface with general orientation control.

Nano letters·2013
Same author

[American head and neck surgery progress of in 2012].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2013
Same author

A compact thermo-optical multimode-interference silicon-based 1 × 4 nano-photonic switch.

Optics express·2013
Same author

Experimental demonstration of 110-Gb/s unsynchronized band-multiplexed superchannel coherent optical OFDM/OQAM system.

Optics express·2013
Same author

Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy.

Carcinogenesis·2013
Same author

Enhanced molecular transport in hierarchical silicalite-1.

Langmuir : the ACS journal of surfaces and colloids·2013

相关实验视频

Updated: Sep 19, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K

基于多视图的异构图对比学习用于药物向相互作用预测.

Chao Li1, Lichao Zhang1, Guoyi Sun1

  • 1College of Electronic and Information Engineering, Shandong University of Science and Technology, Qianwangang Road No. 579, Huangdao District, Qing Dao, 266590, Shandong, China.

Journal of biomedical informatics
|June 4, 2025
PubMed
概括

这项研究引入了一种新的多视图基于异质图对比学习用于药物向相互作用预测 (HGCML-DTI) 方法. HGCML-DTI有效地整合了拓和语义信息,大大提高了药物向相互作用预测的准确性.

关键词:
具有对比性的多视角学习.药物目标相互作用预测预测.不同质的图形是不同的图形.

更多相关视频

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

相关实验视频

Last Updated: Sep 19, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

科学领域:

  • 计算生物学是一种计算生物学.
  • 生物信息学是一种生物信息学.
  • 药物发现 药物发现

背景情况:

  • 药物向相互作用 (DTI) 的预测对于加速药物发现至关重要.
  • 现有的方法往往难以整合拓和语义信息,并保持特征多样性.
  • 挑战包括信息整合不足和图形卷积运算中的表示多样性减少.

研究的目的:

  • 提出一个新的范式,多视图基于异构图对比学习用于药物向相互作用预测 (HGCML-DTI).
  • 解决DTI预测中信息整合不足和代表性多样性减少的局限性.
  • 提高学习特征的表达力和区分能力,用于DTI预测.

主要方法:

  • 构建药物-蛋白质异质图,并使用加权图卷积网络 (GCN) 来导出节点表示.
  • 将药物-蛋白质对 (DPP) 的拓和语义图集成到统一的公共图中.
  • 采用多通道图形神经网络和多视图对比学习策略来学习DPP表示并保持多样性.
  • 使用多层感知器 (MLP) 进行DTI识别.

主要成果:

  • 拟议的HGCML-DTI方法在六个现实数据集中显著优于七个竞争基线.
  • 在药物向相互作用 (DTI) 预测任务中表现卓越.
  • 验证了结合多视角学习和对比策略的有效性.

结论:

  • 通过整合多种信息来源,HGCML-DTI范式有效地解决了DTI预测的关键挑战.
  • 该研究强调了多视角学习和对比策略对于推进DTI预测的重要性.
  • 拟议的方法在药物发现和开发中比现有的最先进的方法有了显著的改进.